For CCL20, we observed elevated expression in HCC cell lines upon treatment with DAC, but not in non-tumor cell lines, suggesting that CCL20 methylation status may be specifically associated with HCC prognosis. The gene discussed is CCL20; the disease is hepatocellular carcinoma.